Drug Shortage Report for METHOTREXATE INJECTION USP

Last updated on 2019-05-28 History
Report ID 81825
Drug Identification Number 02182971
Brand name METHOTREXATE INJECTION USP
Common or Proper name Methotrexate
Company Name PFIZER CANADA ULC
Active Ingredient(s) METHOTREXATE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 100mL Vial
ATC code L01BA
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-04-19
Actual start date 2019-04-24
Estimated end date 2019-05-31
Actual end date 2019-05-16
Shortage status Resolved
Updated date 2019-05-28
Company comments Other presentation are available
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2019-05-28 French Compare
v5 2019-05-28 English Compare
v4 2019-04-20 English Compare
v3 2019-04-16 French Compare
v2 2019-04-16 English Compare
v1 2019-04-16 English Compare